Basit öğe kaydını göster

PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)

dc.contributor.authorFlisiak, R.
dc.contributor.authorMa, X.
dc.contributor.authorCaruntu, F. A.
dc.contributor.authorTak, W. Y.
dc.contributor.authorElkhashab, M.
dc.contributor.authorLin, L.
dc.contributor.authorDinh, P.
dc.contributor.authorMartins, E. B.
dc.contributor.authorCharuworn, P.
dc.contributor.authorMcHutchinson, J. G.
dc.contributor.authorSubramanian, G. M.
dc.contributor.authorLim, S. G.
dc.contributor.authorFoster, G. R.
dc.contributor.authorFung, S.
dc.contributor.authorMorano, L.
dc.contributor.authorMarcellin, P.
dc.contributor.authorTabak, F.
dc.contributor.authorSamuel, D.
dc.contributor.authorAgarwal, K.
dc.contributor.authorIdilman, R.
dc.contributor.authorStrasser, S.
dc.contributor.authorButi, M.
dc.contributor.authorGaeta, G. B.
dc.contributor.authorPapatheodoridis, G.
dc.contributor.authorChan, H. L.
dc.contributor.authorAhn, S. H.
dc.contributor.authorChuang, W. L.
dc.contributor.authorHui, A. J.
dc.contributor.authorMehta, R.
dc.contributor.authorPetersen, J.
dc.contributor.authorLee, C. -M.
dc.date.accessioned2021-03-04T11:08:17Z
dc.date.available2021-03-04T11:08:17Z
dc.identifier.citationChan H. L. , Ahn S. H. , Chuang W. L. , Hui A. J. , Tabak F., Mehta R., Petersen J., Lee C. -. , Ma X., Caruntu F. A. , et al., "PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)", 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 22 - 26 Nisan 2015, cilt.62
dc.identifier.othervv_1032021
dc.identifier.otherav_70c3b9a3-2291-4f4b-9538-db63c47e6964
dc.identifier.urihttp://hdl.handle.net/20.500.12627/77717
dc.identifier.urihttps://doi.org/10.1016/s0168-8278(15)30136-7
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.titlePREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)
dc.typeBildiri
dc.contributor.departmentChinese University of Hong Kong , ,
dc.identifier.volume62
dc.contributor.firstauthorID146409


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster